Roche to buy cell therapy developer Poseida for $1B
MaaT Pharma eyes Phase II after early success in ALS microbiome trial
Amgen says obesity drug caused up to 20% weight loss after a year, but shares drop 10%
Medigene axes staff and refocuses its TCR pipeline
*please scroll down for all the latest news*
